Russian vaccine against coronavirus can enter the market already in mid-August

The vaccine for coronavirus, developed at the National research center. N. F.Gamalei, submitted for examination at the fsbi “Scientific center of expertise of medical application products”. It is expected that it will be registered 10-12 August, an informed source “Interfax”. Five or seven days he took on the test of the vaccine in healthcare.

“After that, as expected, August 15, the vaccine can enter into civil circulation”, – said the source.

Earlier, a source in the government said that the vaccine nits them. Gamalei be registered in the beginning of August, but will be used selectively. According to him, the first vaccine will be given to the people of the so-called risk groups – teachers, doctors, etc., and more than 1,500 volunteers. To finally can be sure of its effectiveness and safety, the source, took five or six months. After that, the vaccine will be launched to the General public, that is, it will be in January-February 2021.

Leave a Reply

Your email address will not be published. Required fields are marked *


Pfizer and Hikma will manufacture ramdevpir

British Hikma announced the start of production of ramdevpir of Gilead, which is currently used for the treatment of patients with COVID-19. A similar agreement for the production of antiretroviral drug Gilead has entered into with Pfizer, writes Reuters. Ramdevpir is one of two drugs that have confirmed efficacy in the treatment of coronavirus infection […]

RNC Pharma: the Russian pharmaceutical manufacturers set an absolute record

The total volume of pharmaceutical production in January-June 2020 reached 232 billion rubles, rate of growth compared to the same period 2019 to 24%, according to the RNC Pharma. Natural dynamics are somewhat more modest: 18.3% packages just for the first half of the domestic companies shipped 2.45 billion packings of medicines. The increase in […]